These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 34995410)

  • 1. Roles for the mycobiome in liver disease.
    Zeng S; Schnabl B
    Liver Int; 2022 Apr; 42(4):729-741. PubMed ID: 34995410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut mycobiome alterations and implications for liver diseases.
    Zeng S; Schnabl B
    PLoS Pathog; 2024 Aug; 20(8):e1012377. PubMed ID: 39116092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease.
    Yadav A; Yadav R; Sharma V; Dutta U
    Indian J Gastroenterol; 2024 Feb; 43(1):112-128. PubMed ID: 38409485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut mycobiome in metabolic diseases: Mechanisms and clinical implication.
    Zhou X; Zhang X; Yu J
    Biomed J; 2024 Jun; 47(3):100625. PubMed ID: 37364760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut mycobiome: The probable determinative role of fungi in IBD patients.
    Beheshti-Maal A; Shahrokh S; Ansari S; Mirsamadi ES; Yadegar A; Mirjalali H; Zali MR
    Mycoses; 2021 May; 64(5):468-476. PubMed ID: 33421192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the gut mycobiome with coronary artery disease severity.
    An K; Jia Y; Xie B; Gao J; Chen Y; Yuan W; Zhong J; Su P; Liu X
    EBioMedicine; 2024 May; 103():105137. PubMed ID: 38703606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the human oral and gut fungal microbiota in patients with metabolic dysfunction-associated fatty liver disease.
    Niu C; Tu Y; Jin Q; Chen Z; Yuan K; Wang M; Zhang P; Luo J; Li H; Yang Y; Liu X; Mao M; Dong T; Tan W; Hu X; Pan Y; Hou L; Ma R; Huang Z
    Front Cell Infect Microbiol; 2023; 13():1157368. PubMed ID: 37180439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut mycobiome: a novel player in chronic liver diseases.
    Jiang L; Stärkel P; Fan JG; Fouts DE; Bacher P; Schnabl B
    J Gastroenterol; 2021 Jan; 56(1):1-11. PubMed ID: 33151407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging role of the gut mycobiome in liver diseases.
    Szóstak N; Figlerowicz M; Philips A
    Gut Microbes; 2023; 15(1):2211922. PubMed ID: 37184158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promises of microbiome-based therapies.
    Bajaj JS; Ng SC; Schnabl B
    J Hepatol; 2022 Jun; 76(6):1379-1391. PubMed ID: 35589257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fecal mycobiome in non-alcoholic fatty liver disease.
    Demir M; Lang S; Hartmann P; Duan Y; Martin A; Miyamoto Y; Bondareva M; Zhang X; Wang Y; Kasper P; Bang C; Roderburg C; Tacke F; Steffen HM; Goeser T; Kruglov A; Eckmann L; Stärkel P; Fouts DE; Schnabl B
    J Hepatol; 2022 Apr; 76(4):788-799. PubMed ID: 34896404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of gut mycobiota in first-episode, drug-naïve Chinese patients with schizophrenia: A pilot study.
    Zhang X; Pan LY; Zhang Z; Zhou YY; Jiang HY; Ruan B
    Behav Brain Res; 2020 Feb; 379():112374. PubMed ID: 31759045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host Factors Associated with Gut Mycobiome Structure.
    Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Schmidt M; Pruss Ł; Milanowska-Zabel K; Kozlowski P; Philips A
    mSystems; 2023 Apr; 8(2):e0098622. PubMed ID: 36786595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut mycobiome: A promising target for colorectal cancer.
    Qin X; Gu Y; Liu T; Wang C; Zhong W; Wang B; Cao H
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188489. PubMed ID: 33278512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Early Life Gut Mycobiome on Child Health.
    Rodriguez KA; Gurung M; Talatala R; Rearick JR; Ruebel ML; Stephens KE; Yeruva L
    Adv Nutr; 2024 Mar; 15(3):100185. PubMed ID: 38311313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composition and Associations of the Infant Gut Fungal Microbiota with Environmental Factors and Childhood Allergic Outcomes.
    Boutin RCT; Sbihi H; McLaughlin RJ; Hahn AS; Konwar KM; Loo RS; Dai D; Petersen C; Brinkman FSL; Winsor GL; Sears MR; Moraes TJ; Becker AB; Azad MB; Mandhane PJ; Subbarao P; Turvey SE; Finlay BB
    mBio; 2021 Jun; 12(3):e0339620. PubMed ID: 34060330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mycobiota of the human body: a spark can start a prairie fire.
    Zhang D; Wang Y; Shen S; Hou Y; Chen Y; Wang T
    Gut Microbes; 2020 Jul; 11(4):655-679. PubMed ID: 32150513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut mycobiota changes in liver diseases: A systematic review.
    Perlin CM; Longo L; Keingeski MB; Picon RV; Álvares-da-Silva MR
    Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37463798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut mycobiome and metabolic diseases: The known, the unknown, and the future.
    Wang L; Zhang K; Zeng Y; Luo Y; Peng J; Zhang J; Kuang T; Fan G
    Pharmacol Res; 2023 Jul; 193():106807. PubMed ID: 37244385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
    Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
    Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.